On September 22, 2025, Reuters reported that Bayer’s subsidiary BlueRock Therapeutics has officially initiated a Phase III clinical trial of its experimental stem cell therapy for Parkinson’s diseas...
Study Confirms Safety and Efficiency of Optimized K562 Feeder Cells for NK Cell ExpansionA new study published in the Annals of Laboratory Medicine (2025) has reported significant progress in the opti...
A new study published in BMC Biotechnology introduces an innovative engineered K562 feeder cell line (K562-4-1BBL-mbIL-21/IL-15) that has demonstrated remarkable performance in NK cell expansion. Rese...
Hillgene, a leading CDMO specializing in end-to-end solutions for viral vectors and cell therapies, is committed to supporting global partners with high-quality, scalable, and regulatory-compliant man...
Hillgene, a global CDMO specializing in end-to-end viral vector and cell therapy manufacturing solutions, is committed to advancing next-generation therapies through high-quality, scalable platforms. ...
The U.S. Food and Drug Administration (FDA) has removed the Risk Evaluation and Mitigation Strategies (REMS) requirements for currently approved BCMA- and CD19-directed CAR-T therapies, the agency ann...
On June 26, Professor Raju Kucherlapati, a world-renowned expert in genetics and medicine and member of the U.S. National Academy of Medicine (NAM), visited UPMED Biotech with his delegation. The two ...
IGC 2024 (the 8th Immuno-Gene and Cell Therapy Conference) was grandly opened on September 6-7 at the Beijing International Convention Center. During the period from 9:00 a.m. to 12:35 p.m. on Septemb...
December 3rd, 2024 "Building Bridges" conference in the global life sciences sector was held at the J Hotel in Shanghai, organized by the Wallonia Export & Investment Agency Investment a...
The 2024 Biopharmaceutical and Synthetic Biology Expert Exchange Conference, along with the Annual Meeting of the Gene Technology Engineering Research Center of the Ministry of Education, was held in ...
In order to improve the efficiency of drug review and approval, the National Medical Products Administration has decided to implement electronic submission of drug registration application materials. ...
On November 29, the State Food and Drug Administration publicly solicited opinions on the "Regulations on the Supervision and Management of Drug Quality by Drug Marketing Authorization Holders&qu...
86 198 5711 6962 
info@hillgene.com 
English
